NVS - Coherus gains as oncology focus leads to job cuts
2024-03-14 11:22:56 ET
More on Coherus BioSciences
- Coherus BioSciences, Inc. (CHRS) Q4 2023 Earnings Call Transcript
- Coherus BioSciences: FDA Approvals Spice Up The Pipeline
- Coherus BioSciences Q4 2023 Earnings Preview
- Biggest stock movers today: Boeing, NuStar Energy, Archer-Daniels-Midland, and more
- Seeking Alpha’s Quant Rating on Coherus BioSciences